NovaBridge Biosciences Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross

NovaBridge Biosciences (NBP) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 19.21 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.

Financial Statements › Shareholders' Equity

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-04-07

NovaBridge Biosciences share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 2.82M shares.
NovaBridge Biosciences share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 16.03M shares.

Period end	Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month	Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month	Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month	Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month	Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month as first filed
2025-12-31	2.82M shares derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07	18.85M shares derived: sum of 2 quarters · filed 2026-04-07		19.21M shares 20-F · filed 2026-04-07
2025-09-30	16.03M shares derived: 6-K 9 month − 6-K 6 month · filed 2025-12-18		16.39M shares 6-K · filed 2025-12-18
2025-06-30		353.88K shares 6-K · filed 2025-10-06
2022-12-31				2.79M shares 20-F · filed 2023-05-01
2021-12-31				2.70M shares 20-F · filed 2023-05-01	133.91K shares 20-F · filed 2022-04-29
2020-09-30			72.00K shares 6-K · filed 2021-02-05